Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey T Tucker

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Journal of Clinical Psychopharmacology|January 8, 2004
Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patientsAmin Rostami-Hodjegan, Ajmal M Amin, Edgar P Spencer, et al.
Biopharmaceutics & Drug Disposition|January 21, 2015
Does age affect gastric emptying time? A model-based meta-analysis of data from premature neonates through to adultsJennifer J Bonner, Pavan Vajjah, Khaled Abduljalil, et al.
Journal of Clinical Psychopharmacology|August 29, 2012
Pharmacokinetic-pharmacodynamic modeling of mood and withdrawal symptoms in relation to plasma concentrations of methadone in patients undergoing methadone maintenance treatmentMohammad-Reza Shiran, Martin S Lennard, Mohammad-Zafar Iqbal, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 3, 2015
In Vitro Characterization of the Human Liver Microsomal Kinetics and Reaction Phenotyping of Olanzapine MetabolismPorntipa Korprasertthaworn, Thomas M Polasek, Michael J Sorich, et al.
British Journal of Clinical Pharmacology|January 10, 2009
Contribution of the activities of CYP3A, CYP2D6, CYP1A2 and other potential covariates to the disposition of methadone in patients undergoing methadone maintenance treatmentMohammad-Reza Shiran, Martin S Lennard, Mohammad-Zafar Iqbal, et al.
Journal of Psychopharmacology (Oxford, England)|February 16, 2006
The impact of experimental design on assessing mechanism-based inactivation of CYP2D6 by MDMA (Ecstasy)Linh M Van, Amir Heydari, Jiansong Yang, et al.
Journal of Psychopharmacology (Oxford, England)|May 23, 2006
Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMAJiansong Yang, Masoud Jamei, Amir Heydari, et al.
Therapeutic Drug Monitoring|September 22, 2005
Can saliva replace plasma for the monitoring of methadone?Mohammad Reza Shiran, Mohammad Hassanzadeh-Khayyat, Mohammad Zafar Iqbal, et al.
Clinical Endocrinology|September 10, 2004
Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiencyPeak M Mah, Richard C Jenkins, Amin Rostami-Hodjegan, et al.
British Journal of Clinical Pharmacology|September 5, 2002
An indirect response model of homocysteine suppression by betaine: optimising the dosage regimen of betaine in homocystinuriaAngela Matthews, Trevor N Johnson, Amin Rostami-Hodjegan, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Journal of Clinical Psychopharmacology|January 8, 2004
Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patientsAmin Rostami-Hodjegan, Ajmal M Amin, Edgar P Spencer, et al.
Biopharmaceutics & Drug Disposition|January 21, 2015
Does age affect gastric emptying time? A model-based meta-analysis of data from premature neonates through to adultsJennifer J Bonner, Pavan Vajjah, Khaled Abduljalil, et al.
Journal of Clinical Psychopharmacology|August 29, 2012
Pharmacokinetic-pharmacodynamic modeling of mood and withdrawal symptoms in relation to plasma concentrations of methadone in patients undergoing methadone maintenance treatmentMohammad-Reza Shiran, Martin S Lennard, Mohammad-Zafar Iqbal, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 3, 2015
In Vitro Characterization of the Human Liver Microsomal Kinetics and Reaction Phenotyping of Olanzapine MetabolismPorntipa Korprasertthaworn, Thomas M Polasek, Michael J Sorich, et al.
British Journal of Clinical Pharmacology|January 10, 2009
Contribution of the activities of CYP3A, CYP2D6, CYP1A2 and other potential covariates to the disposition of methadone in patients undergoing methadone maintenance treatmentMohammad-Reza Shiran, Martin S Lennard, Mohammad-Zafar Iqbal, et al.
Journal of Psychopharmacology (Oxford, England)|February 16, 2006
The impact of experimental design on assessing mechanism-based inactivation of CYP2D6 by MDMA (Ecstasy)Linh M Van, Amir Heydari, Jiansong Yang, et al.
Journal of Psychopharmacology (Oxford, England)|May 23, 2006
Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMAJiansong Yang, Masoud Jamei, Amir Heydari, et al.
Therapeutic Drug Monitoring|September 22, 2005
Can saliva replace plasma for the monitoring of methadone?Mohammad Reza Shiran, Mohammad Hassanzadeh-Khayyat, Mohammad Zafar Iqbal, et al.
Clinical Endocrinology|September 10, 2004
Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiencyPeak M Mah, Richard C Jenkins, Amin Rostami-Hodjegan, et al.
British Journal of Clinical Pharmacology|September 5, 2002
An indirect response model of homocysteine suppression by betaine: optimising the dosage regimen of betaine in homocystinuriaAngela Matthews, Trevor N Johnson, Amin Rostami-Hodjegan, et al.
Pageof 6